Search results
Biohaven doses first subject in Phase I/II tumour treatment study
Clinical Trials Arena via Yahoo Finance· 5 days agoBiohaven has dosed the first subject in its Phase I/II clinical trial of BHV-1510, a trophoblast...
ASCO 2024: STORM presents positive interim Phase I data on RNA inhibitor
Clinical Trials Arena via Yahoo Finance· 1 day agoOther companies that have presented cancer treatment clinical data at ASCO 2024 include Verastem...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 16 hours agoRemeGen Reports Proof-of-Concept Phase I/II Clinical Study Results for Self-Developed, Potential First-in-Class Antibody-Drug Conjugate ...
... Patient Enrolled in Phase II Part of Randomized Phase I/II Trial Evaluating Lead Cancer Vaccine...
Benzinga· 2 days agoCET – Transgene TNG, a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer today announces that the first patient has been enrolled in the Phase ...
Preston BOE faced with decisions about levy, AI, more
AOL· 5 days agoMay 30—By Jeniffer Graham DPNews @DominionPost.com KINGWOOD—After four hours, 38 minutes and three executive sessions, the Preston County Board of Education adjourned—but not before authorizing ...
CHS students sculpt Bowie Elementary students’ monster sketches in literacy project
KLST San Angelo via Yahoo News· 5 days agoThe monstrous drawings of Bowie Elementary School first-graders sprung to life thanks to the work of...
Jordan Jennings’ historic softball season with MaST Community Charter helped ‘find her voice’
Philly.com· 11 hours agoThere’s a cul-de-sac near Bensalem that’s filled with neighbors who likely know more about area high...
Leads Biolabs' Innovative Cancer Treatment LBL-024, an Anti-PDL1/4-1BB Bispecific Antibody Achieved...
The Pendulum· 2 days agoAfter rigorous evaluation by Scientific Program Committee and ASCO Leadership, LBL-024, a bispecific antibody independently developed by Leads Biolabs with global intellectual property rights ...
Strategic Weapons: Betting On Borei and Bulava
Strategy Page· 3 days agoFor the second time since the Soviet Union collapsed in 1991, a submerged Borei class SSBN fired multiple SLBMs (sea launched ballistic missile) in rapid succession. This ...
Live from ASCO 2024 | Ascentage Pharma Releases Updated Data of FAK/ALK/ROS1 Inhibitor APG-2449 in...
Benzinga· 3 days agoSUZHOU, China, and ROCKVILLE, Md., June 1, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related